Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms

Gerhard Müller-Schwefe, Bart Morlion, Karsten Ahlbeck, Eli Alon, Stefano Coaccioli, Flaminia Coluzzi, Frank Huygen, Wolfgang Jaksch, Eija Kalso, Magdalena Kocot-Kępska, Hans Georg Kress, Ana Cristina Mangas, Cesar Margarit Ferri, Philippe Mavrocordatos, Andrew Nicolaou, Concepción Pérez Hernández, Joseph Pergolizzi, Michael Schäfer, Patrick Sichère

Research output: Contribution to journalArticle

Abstract

Chronic low back pain: Chronic pain is the most common cause for people to utilize healthcare resources and has a considerable impact upon patients’ lives. The most prevalent chronic pain condition is chronic low back pain (CLBP). CLBP may be nociceptive or neuropathic, or may incorporate both components. The presence of a neuropathic component is associated with more intense pain of longer duration, and a higher prevalence of co-morbidities. However, many physicians’ knowledge of chronic pain mechanisms is currently limited and there are no universally accepted treatment guidelines, so the condition is not particularly well managed. Diagnosis: Diagnosis should begin with a focused medical history and physical examination, to exclude serious spinal pathology that may require evaluation by an appropriate specialist. Most patients have non-specific CLBP, which cannot be attributed to a particular cause. It is important to try and establish whether a neuropathic component is present, by combining the findings of physical and neurological examinations with the patient's history. This may prove difficult, however, even when using screening instruments. Multimodal management: The multifactorial nature of CLBP indicates that the most logical treatment approach is multimodal: i.e. integrated multidisciplinary therapy with co-ordinated somatic and psychotherapeutic elements. As both nociceptive and neuropathic components may be present, combining analgesic agents with different mechanisms of action is a rational treatment modality. Individually tailored combination therapy can improve analgesia whilst reducing the doses of constituent agents, thereby lessening the incidence of side effects. Conclusions: This paper outlines the development of CLBP and the underlying mechanisms involved, as well as providing information on diagnosis and the use of a wide range of pharmaceutical agents in managing the condition (including NSAIDs, COX-2 inhibitors, tricyclic antidepressants, opioids and anticonvulsants), supplemented by appropriate non-pharmacological measures such as exercise programs, manual therapies, behavioral therapies, interventional pain management and traction. Surgery may be appropriate in carefully selected patients.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalCurrent Medical Research and Opinion
DOIs
StateAccepted/In press - Mar 21 2017

Fingerprint

Low Back Pain
Pain
Chronic Pain
Physical Examination
Therapeutics
Musculoskeletal Manipulations
Tricyclic Antidepressive Agents
Cyclooxygenase 2 Inhibitors
Neurologic Examination
Traction
Non-Steroidal Anti-Inflammatory Agents
Pain Management
Anticonvulsants
Analgesia
Opioid Analgesics
Analgesics
Guidelines
Exercise
Pathology
Morbidity

Keywords

  • Biopsychosocial
  • Chronic low back pain
  • Multifactorial
  • Multimodal treatment
  • Neuropathic
  • Nociceptive
  • Synergistic analgesia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment for chronic low back pain : the focus should change to multimodal management that reflects the underlying pain mechanisms. / Müller-Schwefe, Gerhard; Morlion, Bart; Ahlbeck, Karsten; Alon, Eli; Coaccioli, Stefano; Coluzzi, Flaminia; Huygen, Frank; Jaksch, Wolfgang; Kalso, Eija; Kocot-Kępska, Magdalena; Kress, Hans Georg; Mangas, Ana Cristina; Margarit Ferri, Cesar; Mavrocordatos, Philippe; Nicolaou, Andrew; Hernández, Concepción Pérez; Pergolizzi, Joseph; Schäfer, Michael; Sichère, Patrick.

In: Current Medical Research and Opinion, 21.03.2017, p. 1-12.

Research output: Contribution to journalArticle

Müller-Schwefe, G, Morlion, B, Ahlbeck, K, Alon, E, Coaccioli, S, Coluzzi, F, Huygen, F, Jaksch, W, Kalso, E, Kocot-Kępska, M, Kress, HG, Mangas, AC, Margarit Ferri, C, Mavrocordatos, P, Nicolaou, A, Hernández, CP, Pergolizzi, J, Schäfer, M & Sichère, P 2017, 'Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms', Current Medical Research and Opinion, pp. 1-12. https://doi.org/10.1080/03007995.2017.1298521
Müller-Schwefe, Gerhard ; Morlion, Bart ; Ahlbeck, Karsten ; Alon, Eli ; Coaccioli, Stefano ; Coluzzi, Flaminia ; Huygen, Frank ; Jaksch, Wolfgang ; Kalso, Eija ; Kocot-Kępska, Magdalena ; Kress, Hans Georg ; Mangas, Ana Cristina ; Margarit Ferri, Cesar ; Mavrocordatos, Philippe ; Nicolaou, Andrew ; Hernández, Concepción Pérez ; Pergolizzi, Joseph ; Schäfer, Michael ; Sichère, Patrick. / Treatment for chronic low back pain : the focus should change to multimodal management that reflects the underlying pain mechanisms. In: Current Medical Research and Opinion. 2017 ; pp. 1-12.
@article{ca07a0e8ba0c4aef9611974673fbe25e,
title = "Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms",
abstract = "Chronic low back pain: Chronic pain is the most common cause for people to utilize healthcare resources and has a considerable impact upon patients’ lives. The most prevalent chronic pain condition is chronic low back pain (CLBP). CLBP may be nociceptive or neuropathic, or may incorporate both components. The presence of a neuropathic component is associated with more intense pain of longer duration, and a higher prevalence of co-morbidities. However, many physicians’ knowledge of chronic pain mechanisms is currently limited and there are no universally accepted treatment guidelines, so the condition is not particularly well managed. Diagnosis: Diagnosis should begin with a focused medical history and physical examination, to exclude serious spinal pathology that may require evaluation by an appropriate specialist. Most patients have non-specific CLBP, which cannot be attributed to a particular cause. It is important to try and establish whether a neuropathic component is present, by combining the findings of physical and neurological examinations with the patient's history. This may prove difficult, however, even when using screening instruments. Multimodal management: The multifactorial nature of CLBP indicates that the most logical treatment approach is multimodal: i.e. integrated multidisciplinary therapy with co-ordinated somatic and psychotherapeutic elements. As both nociceptive and neuropathic components may be present, combining analgesic agents with different mechanisms of action is a rational treatment modality. Individually tailored combination therapy can improve analgesia whilst reducing the doses of constituent agents, thereby lessening the incidence of side effects. Conclusions: This paper outlines the development of CLBP and the underlying mechanisms involved, as well as providing information on diagnosis and the use of a wide range of pharmaceutical agents in managing the condition (including NSAIDs, COX-2 inhibitors, tricyclic antidepressants, opioids and anticonvulsants), supplemented by appropriate non-pharmacological measures such as exercise programs, manual therapies, behavioral therapies, interventional pain management and traction. Surgery may be appropriate in carefully selected patients.",
keywords = "Biopsychosocial, Chronic low back pain, Multifactorial, Multimodal treatment, Neuropathic, Nociceptive, Synergistic analgesia",
author = "Gerhard M{\"u}ller-Schwefe and Bart Morlion and Karsten Ahlbeck and Eli Alon and Stefano Coaccioli and Flaminia Coluzzi and Frank Huygen and Wolfgang Jaksch and Eija Kalso and Magdalena Kocot-Kępska and Kress, {Hans Georg} and Mangas, {Ana Cristina} and {Margarit Ferri}, Cesar and Philippe Mavrocordatos and Andrew Nicolaou and Hern{\'a}ndez, {Concepci{\'o}n P{\'e}rez} and Joseph Pergolizzi and Michael Sch{\"a}fer and Patrick Sich{\`e}re",
year = "2017",
month = "3",
day = "21",
doi = "10.1080/03007995.2017.1298521",
language = "English (US)",
pages = "1--12",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Treatment for chronic low back pain

T2 - the focus should change to multimodal management that reflects the underlying pain mechanisms

AU - Müller-Schwefe, Gerhard

AU - Morlion, Bart

AU - Ahlbeck, Karsten

AU - Alon, Eli

AU - Coaccioli, Stefano

AU - Coluzzi, Flaminia

AU - Huygen, Frank

AU - Jaksch, Wolfgang

AU - Kalso, Eija

AU - Kocot-Kępska, Magdalena

AU - Kress, Hans Georg

AU - Mangas, Ana Cristina

AU - Margarit Ferri, Cesar

AU - Mavrocordatos, Philippe

AU - Nicolaou, Andrew

AU - Hernández, Concepción Pérez

AU - Pergolizzi, Joseph

AU - Schäfer, Michael

AU - Sichère, Patrick

PY - 2017/3/21

Y1 - 2017/3/21

N2 - Chronic low back pain: Chronic pain is the most common cause for people to utilize healthcare resources and has a considerable impact upon patients’ lives. The most prevalent chronic pain condition is chronic low back pain (CLBP). CLBP may be nociceptive or neuropathic, or may incorporate both components. The presence of a neuropathic component is associated with more intense pain of longer duration, and a higher prevalence of co-morbidities. However, many physicians’ knowledge of chronic pain mechanisms is currently limited and there are no universally accepted treatment guidelines, so the condition is not particularly well managed. Diagnosis: Diagnosis should begin with a focused medical history and physical examination, to exclude serious spinal pathology that may require evaluation by an appropriate specialist. Most patients have non-specific CLBP, which cannot be attributed to a particular cause. It is important to try and establish whether a neuropathic component is present, by combining the findings of physical and neurological examinations with the patient's history. This may prove difficult, however, even when using screening instruments. Multimodal management: The multifactorial nature of CLBP indicates that the most logical treatment approach is multimodal: i.e. integrated multidisciplinary therapy with co-ordinated somatic and psychotherapeutic elements. As both nociceptive and neuropathic components may be present, combining analgesic agents with different mechanisms of action is a rational treatment modality. Individually tailored combination therapy can improve analgesia whilst reducing the doses of constituent agents, thereby lessening the incidence of side effects. Conclusions: This paper outlines the development of CLBP and the underlying mechanisms involved, as well as providing information on diagnosis and the use of a wide range of pharmaceutical agents in managing the condition (including NSAIDs, COX-2 inhibitors, tricyclic antidepressants, opioids and anticonvulsants), supplemented by appropriate non-pharmacological measures such as exercise programs, manual therapies, behavioral therapies, interventional pain management and traction. Surgery may be appropriate in carefully selected patients.

AB - Chronic low back pain: Chronic pain is the most common cause for people to utilize healthcare resources and has a considerable impact upon patients’ lives. The most prevalent chronic pain condition is chronic low back pain (CLBP). CLBP may be nociceptive or neuropathic, or may incorporate both components. The presence of a neuropathic component is associated with more intense pain of longer duration, and a higher prevalence of co-morbidities. However, many physicians’ knowledge of chronic pain mechanisms is currently limited and there are no universally accepted treatment guidelines, so the condition is not particularly well managed. Diagnosis: Diagnosis should begin with a focused medical history and physical examination, to exclude serious spinal pathology that may require evaluation by an appropriate specialist. Most patients have non-specific CLBP, which cannot be attributed to a particular cause. It is important to try and establish whether a neuropathic component is present, by combining the findings of physical and neurological examinations with the patient's history. This may prove difficult, however, even when using screening instruments. Multimodal management: The multifactorial nature of CLBP indicates that the most logical treatment approach is multimodal: i.e. integrated multidisciplinary therapy with co-ordinated somatic and psychotherapeutic elements. As both nociceptive and neuropathic components may be present, combining analgesic agents with different mechanisms of action is a rational treatment modality. Individually tailored combination therapy can improve analgesia whilst reducing the doses of constituent agents, thereby lessening the incidence of side effects. Conclusions: This paper outlines the development of CLBP and the underlying mechanisms involved, as well as providing information on diagnosis and the use of a wide range of pharmaceutical agents in managing the condition (including NSAIDs, COX-2 inhibitors, tricyclic antidepressants, opioids and anticonvulsants), supplemented by appropriate non-pharmacological measures such as exercise programs, manual therapies, behavioral therapies, interventional pain management and traction. Surgery may be appropriate in carefully selected patients.

KW - Biopsychosocial

KW - Chronic low back pain

KW - Multifactorial

KW - Multimodal treatment

KW - Neuropathic

KW - Nociceptive

KW - Synergistic analgesia

UR - http://www.scopus.com/inward/record.url?scp=85015825059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015825059&partnerID=8YFLogxK

U2 - 10.1080/03007995.2017.1298521

DO - 10.1080/03007995.2017.1298521

M3 - Article

C2 - 28277866

AN - SCOPUS:85015825059

SP - 1

EP - 12

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

ER -